Research - Development - Production

A national high-tech enterprise specializing in R&D and production of peptides and related derivatives.

about_bg

About us

Hangzhou Go Top Peptide Biotech Co., Ltd. was founded in 2014, is a national high-tech enterprise specializing in R&D and production of peptides and related derivatives. It is also a governing unit of Polypeptide Branch of China Biochemical and Pharmaceutical Industry Association. At present, the company has a peptide research and development center in Hangzhou, covering an area of more than 4,000 square meters, and two commercial peptide factories in Shangyu and Anji, Zhejiang, with several complete peptide production lines, several sets of large-scale peptide synthesis equipment, imported HPLC analysis and preparation equipment, and equipped with a GMP standard clean laboratory. The company has passed the ISO9001:2015 quality management system certification.

 

 

Our Products

Our News

  • Introduction and preparation of a promising breakthrough weight loss product, Rutaglutide

    Introduction and preparation of a promising breakthrough weight loss product, Rutaglutide

    Introduction ritaglutide is a triple agonist peptide of glucagon receptor (GCGR), glucose-depen...

  • Improved solid phase synthesis of canaglipin

    Improved solid phase synthesis of canaglipin

    Introduction caglitide (Cagrilintide) is a new long-acting lipidated amylin analog developed by Novo...

  • A new generation of biased GLP-1RA drugs! Enoglutide brings new treatment for obesity

    A new generation of biased GLP-1RA drugs! Enoglutide brings new treatment for obesity

    The global obesity situation is more serious. According to statistics, the number of overweight/obes...

  • Meet CPHI Milan | Guto Biology at 4K56

    Meet CPHI Milan | Guto Biology at 4K56

    From October 6 to 8, 2026, the CPhI Worldwide, the top event of the global pharmaceutical industry,...

Cooperation Partners

  • 清华大学
  • 复旦大学
  • 同济大学
  • 南开大学
  • 西湖大学
  • 浙江大学
  • 浙江中医药大学
  • 1
  • 3
  • 2